EDN1 and familial dilated cardiomyopathy: Therefore, we aim to investigate the ability of Big ET-1 to predict LVRR beyond clinical parameters, as well as its prognostic implications, to improve the current risk stratification of DCM and promote more accurate screening of patients eligible for advanced therapy.